(Q37828450)

English

The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally

scientific article published on April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

The strategies used for treatment of experimental autoimmune neuritis (EAN): a beneficial effect of glatiramer acetate administered intraperitoneally (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

based on heuristic

3

object named as

Joab Chapman

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

object named as

Aviva Katzav

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

author name string

Ramona Aronovich

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

publication date

1 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Clinical Reviews in Allergy & Immunology

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

181-188

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

https://scigraph.springernature.com/pub.10.1007/s12016-010-8246-7

0 references

Copolymer 1: from basic research to clinical application

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Epidemiology of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Guillain-Barré as an autoimmune disease

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Identification of the neuritogen for experimental allergic neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Immunomodulatory therapies in neurologic critical care

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Guillain-Barré syndrome (GBS).

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Guillain-Barré syndrome: an update

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Inhibition of Ras attenuates the course of experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Administration of dehydroepiandrosterone ameliorates experimental autoimmune neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Valproic acid attenuates inflammation in experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Soluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

New cyclooxygenase-2 inhibitors for treatment of experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Human immunoglobulin ameliorates rat experimental autoimmune neuritis.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Antigen-induced suppression of experimental allergic neuritis in the guinea pig

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Brain-derived neurotrophic factor in experimental autoimmune neuritis.

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies

1 reference

https://api.crossref.org/works/10.1007%2FS12016-010-8246-7

21 January 2018

Linomide suppresses experimental autoimmune neuritis in Lewis rats by inhibiting myelin antigen-reactive T and B cell responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Truncation of the neuritogenic peptide bP2(60-70) results in the generation of altered peptide ligands with the potential to interfere with T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of experimental allergic encephalomyelitis by COP1--relevance to multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lovastatin attenuates nerve injury in an animal model of Guillain-Barré syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of treatment with crotapotin on the evolution of experimental autoimmune neuritis induced in Lewis rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of experimental allergic neuritis with synthetic peptides from myelin P2 protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of leukemia inhibitory factor in experimental autoimmune neuritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neutralizing antibodies to IL-18 ameliorate experimental autoimmune neuritis by counter-regulation of autoreactive Th1 responses to peripheral myelin antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel anti-idiotype antibody therapy for lipooligosaccharide-induced experimental autoimmune neuritis: use relevant to Guillain-Barré syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of experimental allergic neuritis by an antibody to the intracellular adhesion molecule ICAM-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective treatment of experimental autoimmune neuritis with human immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guillain–Barré Syndrome—A Classical Autoimmune Disease Triggered by Infection or Vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment and prevention of experimental autoimmune neuritis with superagonistic CD28-specific monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular immunity in inflammatory autoimmune neuropathies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous immunoglobulin and Guillain-Barré syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective treatment of experimental autoimmune neuritis with Fc fragment of human immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Failure of intravenous immunoglobulin (IVIg) therapy in experimental autoimmune neuritis (EAN) of the Lewis rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of acute inflammatory polyneuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain–Barré syndrome and experimental allergic neuritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental allergic neuritis. I. Rat strain differences in the response to bovine myelin antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of rats with experimental allergic neuritis using high dose immunoglobulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental allergic neuritis in the Lewis rat: characterization of the activity of peripheral myelin and its major basic protein,P2

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21234710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12016-010-8246-7

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37828450&oldid=1730018412"